FAQ's

When do you plan to launch?

We are planning to launch in June 2019. We are recruiting companies and investors now to start collaborating.


Please subscribe to our newsletter and we will update you on our progress. 

What are sample Blockchain applications in this sector?

Blockchain technology provides three key capabilities that are missing but required for the life sciences sector to evolve to the next level:

  • Decentralization and increased transparency of transactions
  • Ultra-secure and immutable storage of information
  • Incentivization of key stakeholders


Key use cases for blockchain include:

  • Battling counterfeit drugs
  • Enhancing virtual clinical trials
  • Efficient 3D printing of drugs

How large is this market?

  • The global pharmaceuticals market was worth $934.8 billion in 2017 and will reach $1170 billion in 2021, growing at 5.8%, according to a recent pharma market research report by, The Business Research Company. 
  • We are also working with "MedTech" companies who are in a seperate category but similar size market. 
  • The Initial Coin Offering (ICO) market in 2018 was over $21  billion. Of that figure, Drugs & Healthcare were 1.6% ($332,599,161). 

Cryptocurrency ICO Stats 2018


What am I investing in?

  • You select what company or companies on the platform you want to invest in.  
  • Each company has a choice of the terms they offer to investors. Some might offer a share of profits as a dividend but you do not earn equity in the company. 
  • In other companies you might be receiving a Security Token (STO) which is similar to shares in a company.
  • Many other combinations are offered depending what the company wants and investors will accept. 

How do you "de-risk" my investment?

  • We believe our biggest opportunity is the huge block of institutional investor money on the sidelines that will invest in this approach long term.
  • In the crypto market, there is not the traditional metrics of P/E ratio, EBIDTA and other ways stocks are evaluated.
  • Investing in biotech stocks of publicly traded stocks can be risky regardless of whether investing through the New York Stock Exchange, NASDAQ or other exchanges. 
  • Our objective is to provide transparency to the companies we select for our platform, so investors are informed and make their own assessments.
  • Over time we plan to mirror the traditional equities markets as we build a data stream.


KPMG Report: Cryptoassets have arrived, but what will it take to secure their future? Institutionalization

How risky is it to buy Cryptocurrencies

  • Cryptocurrency, such as Bitcoin, can be extremely volatile; investments can result in remarkable gains, but equally staggering losses.
  • Trading cryptocurrency can be risky. The industry has not been regulated and the currency is not backed up by any kind of government or central bank. But the SEC has been laying out their policies desiring to protect investors but not wanting to stifle innovation. 
  • Even though cryptocurrencies are designed to be theft-proof, there’s still a risk for fraud and cyber-crime. Evaluating the technical security of exchanges and what jurisdiction they are located in is also a factor to consider.

  

Forbes: Despite What You Hear, The ICO Is Not Over